We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$22.7B
AUM Growth
+$2.61B
Cap. Flow
+$1.88B
Cap. Flow %
8.3%
Top 10 Hldgs %
32.91%
Holding
930
New
47
Increased
619
Reduced
193
Closed
47

Sector Composition

Rank Sector Weight
1 Materials 56.29%
2 Energy 16.8%
3 Healthcare 6.46%
4 Technology 3.59%
5 Industrials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUMC icon
201
Yum China
YUMC
$14.9B
$13.7M 0.06%
+503,620
New +$13.5M
BBWI icon
202
Bath & Body Works
BBWI
$4.01B
$13.6M 0.06%
356,134
+316,770
+805% +$14.3M
MDT icon
203
Medtronic
MDT
$107B
$13.5M 0.06%
167,504
+17,205
+11% +$1.34M
FSK icon
204
FS KKR Capital
FSK
$2.98B
$13.5M 0.06%
343,470
+75,186
+28% +$3.08M
GRFS
205
Grifois
GRFS
$5.16B
$13.4M 0.06%
711,514
+38,266
+6% +$664K
YUM icon
206
Yum! Brands
YUM
$41B
$13.2M 0.06%
+207,326
New +$13.5M
STT icon
207
State Street
STT
$50.9B
$13.2M 0.06%
166,234
+18,552
+13% +$1.47M
AXP icon
208
American Express
AXP
$223B
$13.2M 0.06%
166,854
-133,709
-44% -$10.5M
BNY
209
Bank of New York Mellon
BNY
$108B
$13M 0.06%
275,694
+26,140
+10% +$1.22M
PPP
210
DELISTED
Primero Mining Corp
PPP
$12.9M 0.06%
23,471,756
+5,600,386
+31% +$3.95M
UTHR icon
211
United Therapeutics
UTHR
$26.3B
$12.6M 0.06%
93,382
+16,540
+22% +$2.51M
BRK.B icon
212
Berkshire Hathaway Class B
BRK.B
$1.07T
$12.6M 0.06%
75,579
-59,374
-44% -$9.93M
TSRO
213
DELISTED
TESARO, Inc.
TSRO
$12.3M 0.05%
80,096
+1,290
+2% +$210K
XLF icon
214
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$12.2M 0.05%
+512,312
New +$12.3M
MDLZ icon
215
Mondelez International
MDLZ
$77.7B
$12.1M 0.05%
280,714
+21,895
+8% +$970K
MAIN icon
216
Main Street Capital
MAIN
$4.97B
$11.9M 0.05%
310,470
+77,273
+33% +$2.85M
KMI.PRA
217
DELISTED
Kinder Morgan, Inc.
KMI.PRA
$11.9M 0.05%
238,116
+11,773
+5% +$578K
CRL icon
218
Charles River Laboratories
CRL
$10.9B
$11.8M 0.05%
131,185
+7,228
+6% +$614K
AMT.PRB
219
DELISTED
American Tower Corporation
AMT.PRB
$11.4M 0.05%
102,315
+5,058
+5% +$532K
NEE.PRR
220
DELISTED
NextEra Energy, Inc.
NEE.PRR
$11.4M 0.05%
223,233
+11,036
+5% +$557K
ALKS icon
221
Alkermes
ALKS
$8.82B
$11.4M 0.05%
194,592
+11,353
+6% +$644K
MRVL icon
222
Marvell Technology
MRVL
$174B
$11.1M 0.05%
725,654
+231,666
+47% +$3.57M
CDNS icon
223
Cadence Design Systems
CDNS
$90B
$11M 0.05%
351,412
+95,447
+37% +$2.79M
DCUD
224
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
$10.6M 0.05%
208,351
+10,301
+5% +$516K
KBE icon
225
State Street SPDR S&P Bank ETF
KBE
$1.64B
$10.5M 0.05%
244,148
+18,922
+8% +$833K

Similar funds

VanEck Associates's Q1 2017 Portfolio in Review

As of Q1 2017, VanEck Associates held 930 positions worth $22.7B, up 13% from $20.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

VanEck Associates deployed $1.88B of net new capital in Q1 2017, opening 47 new positions and adding to 619 existing holdings. Its largest new stake was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.

By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 54% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was SM Energy, an estimated $89.9M trimmed.

  • VanEck Associates's largest Q1 2017 buy was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.
  • VanEck Associates added most to B2Gold in Q1 2017, an estimated $127M increase.
  • VanEck Associates's biggest Q1 2017 reduction was SM Energy, cutting an estimated $89.9M.
  • VanEck Associates fully exited Invesco DB US Dollar Index Bullish Fund in Q1 2017, selling an estimated $20.2M.
  • VanEck Associates's ten largest holdings make up 33% of its $22.7B portfolio in Q1 2017.
  • VanEck Associates opened 47 new positions and closed 47 in Q1 2017.
  • VanEck Associates's portfolio value rose 13% quarter-over-quarter to $22.7B.

Based on VanEck Associates's 13F filing for Q1 2017, filed 11 May 2017.